Medicare Enrolled
Dr. Gordon Mitchell, MD
Cardiovascular Disease · Bryan, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mitchell from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mitchell? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mitchell
Dr. Gordon Mitchell is a cardiovascular disease in Bryan, TX, with 20 years in practice. Based on federal Medicare data, Dr. Mitchell performed 9,112 Medicare services across 3,295 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mitchell received a total of $11,592 from 51 pharmaceutical and/or device companies across 802 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mitchell is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 4% volume in TX$ $11,592 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,112
Medicare services
Top 4% in TX for cardiovascular disease
3,295
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~456 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,441 | $87 | $305 |
| Remote patient monitoring management, 20 min/month | 906 | $36 | $97 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 904 | $30 | $79 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 895 | $46 | $161 |
| Remote patient monitoring device, 30 days | 653 | $37 | $106 |
| Electrocardiogram (EKG), 12-lead | 580 | $10 | $50 |
| Hospital follow-up visit, moderate complexity | 540 | $61 | $210 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 462 | $26 | $145 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 433 | $19 | $80 |
| Regadenoson injection (Lexiscan) for heart stress test | 405 | $44 | $245 |
| Echocardiogram, transthoracic | 290 | $133 | $635 |
| Remote pacemaker monitoring, 90 days | 242 | $20 | $100 |
| Remote pacemaker/defibrillator monitoring, 90 days | 239 | $15 | $70 |
| Initial hospital admission, moderate complexity | 139 | $95 | $400 |
| EKG interpretation and report | 130 | $6 | $53 |
| Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | 109 | $35 | $94 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 104 | $54 | $220 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 99 | $601 | $766 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 95 | $1,077 | $3,800 |
| New patient office visit (45-59 min) | 67 | $112 | $472 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 66 | $51 | $110 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 45 | $13 | $36 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 44 | $131 | $515 |
| Programming of dual lead pacemaker system | 40 | $36 | $131 |
| Cardiac catheterization | 26 | $206 | $931 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 24 | $9 | $45 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 23 | $17 | $67 |
| Heart rhythm recording of continous external ekg over 8-15 days | 20 | $9 | $45 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 18 | $18 | $80 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 18 | $39 | $105 |
| Office visit, established patient (20-29 min) | 16 | $66 | $205 |
| Ultrasound of heart, follow-up | 14 | $14 | $75 |
| External shock to heart to regulate heart beat | 13 | $84 | $355 |
| Ultrasound of leg arteries or artery grafts | 12 | $183 | $530 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.1% high complexity
7.9% medium
82.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,592
Total received (2018-2024)
Avg $1,656/year across 7 years
Top 29% in TX for cardiovascular disease
51
Companies
802
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,592 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,487
2023$2,001
2022$1,786
2021$1,830
2020$1,345
2019$1,745
2018$1,397
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$1,682
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$1,556
Novartis Pharmaceuticals Corporation
$1,010
Medtronic, Inc.
$844
E.R. Squibb & Sons, L.L.C.
$800
Janssen Pharmaceuticals, Inc
$693
Medtronic Vascular, Inc.
$452
PFIZER INC.
$438
Baxter Healthcare
$373
Esperion Therapeutics, Inc.
$345
Merck Sharp & Dohme LLC
$333
Abbott Laboratories
$330
SANOFI-AVENTIS U.S. LLC
$326
Amarin Pharma Inc.
$278
Regeneron Healthcare Solutions, Inc.
$200
AstraZeneca Pharmaceuticals LP
$193
Gilead Sciences, Inc.
$123
BOSTON SCIENTIFIC CORPORATION
$123
Boston Scientific Corporation
$119
AngioDynamics, Inc.
$118
Kestra Medical Technology Services, Inc.
$117
Alnylam Pharmaceuticals Inc.
$112
Kiniksa Pharmaceuticals International, plc
$80
iRhythm Technologies, Inc.
$74
Boehringer Ingelheim Pharmaceuticals, Inc.
$67
ABIOMED
$67
Merck Sharp & Dohme Corporation
$56
Kiniksa Pharmaceuticals, Ltd.
$54
Arbor Pharmaceuticals, Inc.
$53
Novo Nordisk Inc
$48
Tactile Systems Technology Inc
$45
Kowa Pharmaceuticals America, Inc.
$43
Vital Connect, Inc
$42
ATRICURE, INC.
$40
Actelion Pharmaceuticals US, Inc.
$35
Otsuka America Pharmaceutical, Inc.
$35
CHIESI USA, INC.
$32
MEDICOMP INC
$28
CHF Solutions, Inc
$26
Daiichi Sankyo Inc.
$23
Astellas Pharma US Inc
$20
Terumo Medical Corporation
$19
CVRx, Inc.
$18
PORTOLA PHARMACEUTICALS, INC.
$18
Chiesi USA, Inc.
$18
BIOTRONIK INC.
$18
Allergan Inc.
$15
Siemens Medical Solutions USA, Inc.
$14
Avinger Inc.
$14
Edwards Lifesciences Corporation
$14
ARBOR PHARMACEUTICALS, INC.
$12
Top 3 companies account for 36.6% of total payments
Associated products mentioned in payments ›
ADVISA DR MRI SURESCAN · AMPLIA MRI QUAD CRT-D SURESCAN · ARTIS icono biplane · ATRICLIP LAA EXCLUSION SYSTEM · AURYON LASER SYSTEM 100-120 VAC · AVEIR · AZURE XT DR MRI SURESCAN · Aquadex · Arcalyst · Assure WCD · Azure · BEVYXXA · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CHANTIX · CLARIA MRI QUAD CRT-D SURESCAN · CLEVIPREX 50MG/100ML · COBALT DR MRI SURESCAN · CONFIRM RX · CardioMEMS HF System · CareLink · Confirm Rx · CoreValve Evolut · Corlanor · DISEASE STATE · ELIQUIS · ENTRESTO · EVERA MRI XT DR SURESCAN · Edarbi · Edarbyclor · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FLEXITOUCH · Flexitouch Plus · GLIDESHEATH SLENDER · Hillrom - Cardiac Ambulatory Monitor · Hillrom - Carnation Ambulatory Monitor · INJECTAFER · Impella · JARDIANCE · KENGREAL · LEQVIO · LEXISCAN · LINQ II · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MICRA · MULTAQ · MYCARELINK · Mitra Clip system · MyCareLink Smart · NEXLETOL · ONPATTRO · Ozempic · PANTHERIS · PERCEPTA QUAD CRT-P MRI SURESCAN · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · Reveal LINQ · Rybelsus · SAMSCA · SELECTSECURE · SOLARA QUAD CRT-P MRI SURESCAN · SureScan · TELEPATCH CARDIAC MONITOR · UPTRAVI · VERQUVO · VISA AF MRI VR SURESCAN · VITALPATCH RTM · Vascepa · WATCHMAN · WATCHMAN Access System · XARELTO · ZIO Patch · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $127 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
16
Per 100K population
6.7
County median income
$58,388
Nearest hospital
CHI ST JOSEPH HEALTH REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mitchell is a clinical cardiology specialist, with above-average Medicare volume (top 4% in TX), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mitchell experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mitchell performed 1,441 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mitchell receive payments from pharmaceutical companies?
Yes. Dr. Mitchell received a total of $11,592 from 51 companies across 802 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mitchell's costs compare to other cardiovascular diseases in Bryan?
Dr. Mitchell's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mitchell) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Bryan
Browse cardiovascular diseases in Bryan ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology